{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:09:53Z","timestamp":1790744993881,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Population rates of obesity, hypertension, diabetes, age, and race can be used in simulation models to develop projections of ESRD incidence and prevalence. Such projections can inform long-range planning for ESRD resources needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used an open compartmental simulation model to estimate the incidence and prevalence of ESRD in the United States through 2030 on the basis of wide-ranging projections of population obesity and ESRD death rates. Population trends in age, race, hypertension, and diabetes were on the basis of data from the Centers for Disease Control and Prevention\u2019s National Health and Nutrition Examination Survey and the US Census.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The increase in ESRD incidence rates within age and race groups has leveled off and\/or declined in recent years, but our model indicates that population changes in age and race distribution, obesity and diabetes prevalence, and ESRD survival will result in a 11%\u201318% increase in the crude incidence rate from 2015 to 2030. This incidence trend along with reductions in ESRD mortality will increase the number of patients with ESRD by 29%\u201368% during the same period to between 971,000 and 1,259,000 in 2030.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The burden of ESRD will increase in the United States population through 2030 due to demographic, clinical, and lifestyle shifts in the population and improvements in RRT. Planning for ESRD resource allocation should allow for substantial continued growth in the population of patients with ESRD. Future interventions should be directed to preventing the progression of CKD to kidney failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.2018050531","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T15:45:24Z","timestamp":1545061524000},"page":"127-135","source":"Crossref","is-referenced-by-count":315,"title":["Projecting ESRD Incidence and Prevalence in the United States through 2030"],"prefix":"10.1681","volume":"30","author":[{"given":"Keith P.","family":"McCullough","sequence":"first","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, Michigan; and Departments of"},{"name":"Epidemiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal","family":"Morgenstern","sequence":"additional","affiliation":[{"name":"Epidemiology and"},{"name":"Environmental Health Sciences, School of Public Health,"},{"name":"Department of Urology, Medical School, Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Saran","sequence":"additional","affiliation":[{"name":"Epidemiology and"},{"name":"Metabolism, Endocrinology, and Diabetes and"},{"name":"Nephrology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Herman","sequence":"additional","affiliation":[{"name":"Epidemiology and"},{"name":"Metabolism, Endocrinology, and Diabetes and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, Michigan; and Departments of"},{"name":"Nephrology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/comjnl\/7.4.308","article-title":"A simplex method for function minimization.","volume":"7","author":"Nelder","year":"1965","journal-title":"Comput J"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011-2012.","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016.","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"key":"B15-20230819","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/sim.1481","article-title":"Prediction of cancer incidence in the Nordic countries: Empirical comparison of different approaches.","volume":"22","author":"M\u00f8ller","year":"2003","journal-title":"Stat Med"},{"issue":"Suppl","key":"B16-20230819","first-page":"S3","article-title":"End-stage renal disease: Magnitude of the problem, prognosis of future trends and possible solutions.","volume":"50","author":"Port","year":"1995","journal-title":"Kidney Int Suppl"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1681\/ASN.V12122753","article-title":"Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.","volume":"12","author":"Xue","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1681\/ASN.2005010112","article-title":"Projecting the number of patients with end-stage renal disease in the United States to the year 2015.","volume":"16","author":"Gilbertson","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/1744-9987.12266","article-title":"Anticipated increase in the number of patients who require dialysis treatment among the aging population of Japan.","volume":"19","author":"Wakasugi","year":"2015","journal-title":"Ther Apher Dial"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1046\/j.1523-1755.2002.00678.x","article-title":"Cost savings of home nocturnal versus conventional in-center hemodialysis.","volume":"62","author":"McFarlane","year":"2002","journal-title":"Kidney Int"},{"key":"B23-20230819","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.ackd.2011.09.001","article-title":"Peritoneal dialysis versus hemodialysis: Risks, benefits, and access issues.","volume":"18","author":"Sinnakirouchenan","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"B25-20230819","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2215\/CJN.07680717","article-title":"Are SGLT2 inhibitors ready for prime time for CKD?","volume":"13","author":"Pecoits-Filho","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B26-20230819","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/ajt.13490","article-title":"A cost-benefit analysis of government compensation of kidney donors.","volume":"16","author":"Held","year":"2016","journal-title":"Am J Transplant"},{"key":"B27-20230819","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"B28-20230819","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1377\/hlthaff.2016.1625","article-title":"New kidney allocation system associated with increased rates of transplants among black and Hispanic patients.","volume":"36","author":"Melanson","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"B31-20230819","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12882-015-0084-7","article-title":"PAlliative Care in chronic Kidney diSease: The PACKS study--quality of life, decision making, costs and impact on carers in people managed without dialysis.","volume":"16","author":"Noble","year":"2015","journal-title":"BMC Nephrol"},{"key":"B32-20230819","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.socscimed.2012.03.003","article-title":"Bigger bodies: long-term trends and disparities in obesity and body-mass index among US adults, 1960\u20132008","volume":"75","author":"Ljungvalla","year":"2012","journal-title":"Social science & medicine"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201901000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:30:40Z","timestamp":1786131040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201901000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2018050531","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,17]]}}}